Open Account
Demo Account
About Us
Real-time Quotes & News
Market Analysis
Economic Calendar
Daily Market Analysis
Trading Platform
Platform Overview
How To Use
Terms
All Terms
Deposit & Withdrawal
Promotion
FAQ
Contact
繁
简
EN
User Login
Open Account
Demo Account
繁
简
EN
User Login
Open Account
Demo Account
About Us
About Aspire
Features of Aspire
Real-time Quotes & News
Real-time Quotes
Real-time News
Market Analysis
Economic Calendar
Market Analysis
Trading Platform
Meta Trader 5
Platform Features
Terms
All Terms
Deposit & Withdrawal
Promotion
FAQ
Contact
About Us
Terms
Metals Market
Trading Platform
Market Analysis
Promotion
FAQ
Contact
繁
简
EN
Swiss National Bank says medium-term inf pressure has risen only slightly.
2026-09-24
Swiss National Bank says medium-term inf pressure has risen only slightly.
Back
Other News
2026-09-24
Individual Stock News 1. China Xuyang Group (01907.HK) plans to invest RMB 507 million in Xiangfu New Energy to help it rapidly expand its production capacity. 2. Nine Dragons Paper (02689.HK) released its annual results: profit attributable to sha
Individual Stock News 1. China Xuyang Group (01907.HK) plans to invest RMB 507 million in Xiangfu New Energy to help it rapidly expand its production capacity. 2. Nine Dragons Paper (02689.HK) released its annual results: profit attributable to shareholders was RMB 3.581 billion, an increase of 102.62% year-on-year. 3. Vision Holdings (00862.HK) released its annual results: loss attributable to shareholders was HKD 437 million, an increase of 678.29% year-on-year. 4. Estun (02715.HK) plans to acquire approximately 44.8601% of Estun Jiangsu Intelligent's shares, increasing its stake to approximately 95.0107%. 5. Fosun Pharma (02696.HK) entered into a cooperation and licensing agreement with Amberstone for two T-cell connector products. 6. Asia Pacific Resources (01104.HK) released its annual results: profit attributable to shareholders was HK$1.711 billion, an increase of 601.69% year-on-year. 7. Hengrui Medicine (01276.HK): HRS-7172 tablets, adebelimab injection, and other drugs received drug clinical trial approval notices. 8. Lepu Biopharma (02157.HK): The clinical study results of CMG901 (AZD0901) were selected for the LBA and will be announced at the Chairman's Symposium. A total of 4 clinical study results were selected for the 2026 ESMO Congress.
2026-09-23
Iran's First Vice President Arif: The president will demonstrate Iran's strength and development to the world and respond to the violence and unjust sanctions imposed by adversaries.
Iran's First Vice President Arif: The president will demonstrate Iran's strength and development to the world and respond to the violence and unjust sanctions imposed by adversaries.
Chat with us
, powered by
LiveChat